TMTheresa Munyombwe

Theresa Munyombwe

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Theresa Munyombwe has a total of 122 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The relationship between cardiovascular health and common mental disorders among adults aged ≤ 50 years: a systematic review of observational studies

    by Audrey Moyo, Theresa Munyombwe, Nasheeta Peer, Siyabonga Eric Dubazana, Nokwanda Sithole, Innocent Maposa, Darshini Govindasamy

    Background: Depression and anxiety are common among younger adults and contribute to adverse physical and social outcomes. Evidence suggests a potential bidirectional relationship between common mental disorders (CMDs) and cardiovascular health (CVH). However, this has not been directly established. This review examined the relationship between CVH and CMDs in individuals aged 15–50 years. Methods: MEDLINE (PubMed), APA PsycINFO, Web of Science, and CINAHL (EBSCO) were searched from inception to 4 November 2024. Observational studies reporting depressive or anxiety symptoms and CVH defined by Life’s Simple 7, Life’s Essential 8, or adapted composite indices were eligible. Study quality was appraised using the Newcastle-Ottawa Scale and a narrative synthesis was conducted. Findings: Of 25 full-text articles assessed, 11 studies ( n = 731,650; mean age 22–48 years) met the inclusion criteria. Nine were conducted in the United States, one in China, and one in Puerto Rico. Seven cross-sectional studies reported an inverse association between CVH and CMDs, with higher CVH associated with lower odds or prevalence of depressive and anxiety symptoms. Four studies, including one cohort, found that CMDs were associated with lower CVH, reflected by higher odds of suboptimal CVH, lower prevalence of ideal CVH, and reduced CVH scores. Conclusions: Findings suggest a potential bidirectional relationship between CVH and CMDs among adults, though this is inferred from separate analyses rather than directly established using the same studies. Integrated strategies promoting physical activity, a healthy diet, and stress management, alongside primary care initiatives incorporating behavioural support and screening for cardiovascular and mental health risks, may benefit both conditions. Interpretation is limited by the predominance of cross-sectional studies and heterogeneity in study designs, with most studies conducted in high-income settings. Future research should prioritise longitudinal designs and apply diverse analytical methods to better clarify directionality. Registration: PROSPERO (CRD42024621494).

  • Open Access

    Abnormal myocardial perfusion reserve and myocardial infarction determine cardiovascular outcomes in type 2 diabetes mellitus

    by Noor Sharrack, Kristopher D Knott, Jian L Yeo, Tushar Kotecha, Louise A E Brown, Aldostefano Porcari, Robert D Adam, Gaurav S Gulsin, Sharmaine Thirunavukarasu, Amrit Chowdhary, et al.

    Aims: In individuals with type 2 diabetes mellitus (T2DM), both myocardial ischemia and myocardial infarction (MI) are associated with adverse cardiovascular outcomes. The incremental prognosis of both risks is unknown. We aimed to investigate whether abnormal myocardial perfusion reserve (MPR), as a surrogate marker for ischemia and presence of MI offers incremental prognostic value in predicting major adverse cardiovascular and cerebrovascular events (MACCE) in patients with T2DM. Methods and results: A retrospective multicentre cohort of 572 individuals with T2DM and healthy controls underwent quantitative stress myocardial perfusion cardiovascular magnetic resonance (CMR) to determine MPR and late gadolinium enhancement (LGE) to identify MI. Patients were divided into three groups: MI- and normal MPR, MI+ or abnormal MPR and MI+ and abnormal MPR. Cox proportional hazard models quantified associations between MPR and MI with MACCE (composite of all-cause death, MI, stroke, heart failure hospitalization, and late coronary revascularization>90 days after the CMR scan). Over a median of 28 months (IQR 25–31 months), 81 participants (14%) accrued at least one MACCE, including 25 (4%) deaths. Presence of either abnormal MPR or MI was associated with increased MACCE (MI- and normal MPR: 8% MACCE; MI+ or abnormal MPR: 15% MACCE (adjusted HR compared with normal 1.86 (95% CI 1.06–3.25, P = 0.03)); presence of both MI and abnormal MPR had the highest event rate: 30% MACCE (adjusted HR compared with normal 3.24 (95% CI 1.75–6.01, P < 0.001)). Conclusion: In T2DM, abnormal MPR or MI are associated with MACCE, and the presence of both offers incremental prognostic value.


  • Open Access

    Psychometric properties of health-related quality of life patient reported outcome measures for common cardiovascular conditions: a scoping review and COSMIN analysis

    by Asad Bhatty, Adam B Smith, Martijn Scherrenberg, Mohammad Haris, Chris Wilkinson, Chris P Gale, Theresa Munyombwe

    Aims: Health-related quality of life (HRQoL) is an important measure of disease status and represents a holistic approach to delivering patient-centered care. We conducted a scoping review of HRQoL patient reported outcome measures (PROMs) for cardiovascular diseases (CVDs) and evaluated their psychometric properties. Methods and results: Randomized trials and observational studies that developed and validated HRQoL PROMs for adults with ischaemic heart disease (IHD), aortic stenosis (AS), atrial fibrillation (AF), heart failure (HF), or generic CVD were included, published from inception of databases to 8 February 2025 using PubMed, Web of Science, and Embase. Independent reviewers selected and extracted the psychometric properties of each PROM in accordance with the Consensus-based Standards for the selection of health Measurement Instruments (COSMIN) checklist: content validity, reliability, internal consistency, structural validity, criterion/convergent, cross-cultural validity, measurement error, hypothesis testing, and responsiveness. Each PROM was graded using the Grading of Recommendations Assessment, Development, and Evaluation approach. Of 9430 articles, 220 studies for 38 different PROMs were included (HF n = 17, 45%; AF n = 11, 29%; IHD n = 7, 18%; generic n = 2, 5%; AS n = 1, 3%). Eleven PROMs (29%) satisfied all nine COSMIN criteria; the majority (n = 19, 50%) required further validation and eight were deemed inadequate for clinical use (21%). Conclusion: This scoping review of HRQoL PROMs in individuals with common CVDs found evidence that many PROMs do not fulfill all nine COSMIN criteria for methodological quality, and for some CVDs there is a limited choice of suitable PROMs for HRQoL measurement. There is an opportunity to improve HRQoL evaluation for use within routine care and research.


  • Open Access

    The prevalence and correlates of common mental disorders among adolescents and young adults in rural South Africa: analysis of household survey data informed by lived experience experts

    by Audrey Moyo, Lovemore Nyasha Sigwadhi, Stanley Carries, Nokwanda Sithole, Reuben Christopher Moyo, Arvin Bhana, Peter Suwirakwenda Nyasulu, Eugene Lee Davids, Theresa Munyombwe, Innocent Maposa, et al.

    Key message: A significant proportion of rural AYA report experiencing CMDs, with early parenthood and not being the child of the household head identified as key risk factors. These findings underscore the need for community-and-school-based social support interventions, alongside economic empowerment initiatives, to address the mental health needs of this population.


  • Open Access

    Circulating Blood-Brain Barrier Proteins for Differentiating Ischaemic Stroke Patients from Stroke Mimics

    by Pragati Kakkar, Meaad Almusined, Tarun Kakkar, Theresa Munyombwe, Linetty Makawa, Kirti Kain, Ahamad Hassan, Sikha Saha

    Background: Stroke is one of the leading causes of death and disability worldwide. The diagnosis of stroke remains largely clinical, yet widely used stroke scoring systems and brain imaging do not satisfactorily allow the distinction of ischaemic stroke (IS) patients from stroke mimics (SMs). Blood biomarkers are promising tools that could facilitate clinical triage. Methods: This study recruited 66 patients with IS and 24 SMs. The levels of Glial fibrillary acidic protein (GFAP), Neuron-specific enolase (NSE), Neurofilament light chain (NfL) and blood-brain barrier (BBB) proteins [Occludin (OCLN), Zonula occludens 1 (ZO-1), Claudin-5] in blood serum were measured by enzyme-linked immunosorbent assay technique. Biomarker levels in IS patients and SMs were compared using the Mann–Whitney U test. Multivariable logistic regression analysis was used to evaluate the diagnostic performance of biomarkers in combination with the National Institutes of Health Stroke Scale (NIHSS) score. Results: More significant differences in circulating GFAP, NfL, OCLN, ZO-1, and Claudin-5 but not NSE were found in IS patients compared to SMs. A combination of circulating ZO-1, Claudin-5, and OCLN with NIHSS score gives the highest diagnostic accuracy, sensitivity, and specificity. Conclusions: A prediction model with circulating BBB proteins in combination with NIHSS score differentiates between IS patients and SMs.


  • Open Access

    Circulating Blood-Brain Barrier Proteins for Differentiating Ischaemic Stroke Patients from Stroke Mimics

    by Pragati Kakkar, Meaad Almusined, Tarun Kakkar, Theresa Munyombwe, Linetty Makawa, Kirti Kain, Ahamad Hassan, Sikha Saha

    Background: Stroke is one of the leading causes of death and disability worldwide. The diagnosis of stroke remains largely clinical, yet widely used stroke scoring systems and brain imaging do not satisfactorily allow distinction of ischaemic stroke (IS) patients from stroke mimics (SM). Blood biomarkers are promising tools that could facilitate clinical triage. Methods: This study recruited 66 patients with IS and 24 SM. The levels of Glial fibrillary acidic protein (GFAP), Neuron-specific enolase (NSE), Neurofilament light chain (NfL) and blood-brain barrier (BBB) proteins [Occludin (OCLN), Zonula occludens 1 (ZO-1), Claudin-5] in blood serum were measured by enzyme-linked immunosorbent assay technique. Biomarker levels in IS patients and SM was compared using the Mann–Whitney U test. Multivariable logistic regression analysis was used to evaluate the diagnostic performance of biomarkers in combination with the National Institutes of Stroke Scale (NIHSS) score. Results: Significant differences in circulating GFAP, NfL, OCLN, ZO-1, and Claudin-5 but not NSE in IS patients compared to SM. The combination of circulating ZO-1, Claudin-5, and OCLN with NIHSS score gives the highest diagnostic accuracy, sensitivity, and specificity. Conclusion: A prediction model with Circulating BBB proteins in combination with NIHSS score differentiates between IS patients and SM.


  • Open Access

    Associations of health-related quality of life with major adverse cardiovascular and cerebrovascular events for individuals with ischaemic heart disease: systematic review, meta-analysis and evidence mapping

    by Anzhela Soloveva, Chris P Gale, Han Naung Tun, Ben Hurdus, Suleman Aktaa, Victoria Palin, Teumzghi F Mebrahtu, Harriette Van Spall, Gorav Batra, Tatendashe Bernadette Dondo, et al.

    Objective: To investigate the association between health-related quality of life (HRQoL) and major adverse cardiovascular and cerebrovascular events (MACCE) in individuals with ischaemic heart disease (IHD). Methods: Medline(R), Embase, APA PsycINFO and CINAHL (EBSCO) from inception to 3 April 2023 were searched. Studies reporting association of HRQoL, using a generic or cardiac-specific tool, with MACCE or components of MACCE for individuals with IHD were eligible for inclusion. Risk of bias was assessed using the Newcastle-Ottawa Quality Assessment Scale to assess the quality of the studies. Descriptive synthesis, evidence mapping and random-effects meta-analysis were performed stratified by HRQoL measures and effect estimates. Between-study heterogeneity was assessed using the Higgins I2 statistic. Results: Fifty-one articles were included with a total of 134 740 participants from 53 countries. Meta-analysis of 23 studies found that the risk of MACCE increased with lower baseline HeartQoL score (HR 1.49, 95% CI 1.16 to 1.93) and Short Form Survey (SF-12) physical component score (PCS) (HR 1.39, 95% CI 1.28 to 1.51). Risk of all-cause mortality increased with a lower HeartQoL (HR 1.64, 95% CI 1.34 to 2.01), EuroQol 5-dimension (HR 1.17, 95% CI 1.12 to 1.22), SF-36 PCS (HR 1.29, 95% CI 1.19 to 1.41), SF-36 mental component score (HR 1.18, 95% CI 1.08 to 1.30). Conclusions: This study found an inverse association between baseline values or change in HRQoL and MACCE or components of MACCE in individuals with IHD, albeit with between-study heterogeneity. Standardisation and routine assessment of HRQoL in clinical practice may help risk stratify individuals with IHD for tailored interventions. PROSPERO registration number: CRD42021234638.


  • Open Access

    Cohort profile: Evaluation of the Methods and Management of Acute Coronary Events (EMMACE) longitudinal cohort

    by Theresa Munyombwe, Tatendashe B Dondo, Marlous Hall, Ramesh Nadarajah, Ben Hurdus, Suleman Aktaa, Mohammad Haris, Adam Keeley, Robert West, Alistair Hall, et al.

    Aims: The Evaluation of the Methods and Management of Acute Coronary Events (EMMACE) longitudinal cohort study aims to investigate health trajectories of individuals following hospitalization for myocardial infarction (MI). Methods and results: EMMACE is a linked multicentre prospective cohort study of 14 899 patients with MI admitted to 77 hospitals in England who participated in the EMMACE-3 and -4 studies between 1st November 2011 and 24th June 2015. Long-term follow-up of the EMMACE cohorts was conducted through the EMMACE-XL (27th September 2020 to 31st March 2022) and EMMACE-XXL (1st July 2021 to 1st July 2023) studies. EMMACE collected individual participant data for health-related quality of life (HRQoL) measured by three-level EuroQol five-dimension and visual analogy scale at admission, 1 month, 6 months, 12 months, and 10 years follow-up, as well as medications, medication adherence, beliefs about medicines, Satisfaction with Information about Medicines Scale, and illness perceptions. Participant data were deterministically linked to the Myocardial Infarction National Audit Project (MINAP) for information on baseline treatments and comorbidities, Hospital Episode Statistics Admitted Patient Care (for cause-specific hospitalization data), and the Office for National Statistics (for mortality data) up to 2020. Conclusion: EMMACE is a nationwide prospective cohort that will provide unique insights into fatal and non-fatal outcomes, medication adherence, and HRQoL following MI. Trial registration: ClinicalTrials.gov NCT01808027 and NCT01819103


  • Open Access

    Sex differences in health-related quality of life trajectories following myocardial infarction: national longitudinal cohort study

    by Tatendashe Bernadette Dondo, Theresa Munyombwe, Marlous Hall, Ben Hurdus, Anzhela Soloveva, Gerard Oliver, Suleman Aktaa, Robert M West, Alistair S Hall, Chris P Gale

    Objectives To investigate sex-based differences in baseline values and longitudinal trajectories of health-related quality of life (HRQoL) in a large cohort of myocardial infarction (MI) survivors after adjusting for other important factors. Design Longitudinal cohort study. Setting Population-based longitudinal study the Evaluation of the Methods and Management of Acute Coronary Events study linked with national cardiovascular registry. Data were collected from 77 hospitals in England between 1 November 2011 and 24 June 2015. Participants 9551 patients with MI. Patients were eligible for the study if they were ≥18 years of age. Primary and secondary outcome measures HRQoL was measured by EuroQol five-dimension, visual analogue scale (EQ-5D, EQ VAS) survey at baseline, 1, 6 and 12 months after discharge. Multi-level linear and logistic regression models coupled with inverse probability weighted propensity scoring were used to evaluate sex differences in HRQoL following MI. Results Of the 9551 patients with MI and complete data on sex, 25.1% (2,397) were women. At baseline, women reported lower HRQoL (EQ VAS (mean (SD) 59.8 (20.4) vs 64.5 (20.9)) (median (IQR) 60.00 (50.00–75.00) vs 70.00 (50.00–80.00))) (EQ-5D (mean (SD) 0.66 (0.31) vs 0.74 (0.28)) (median (IQR) 0.73 (0.52–0.85) vs 0.81 (0.62–1.00))) and were more likely to report problems in each HRQoL domain compared with men. In the covariate balanced and adjusted multi-level model sex differences in HRQoL persisted during follow-up, with lower EQ VAS and EQ-5D scores in women compared with men (adjusted EQ VAS model sex coefficient: −4.41, 95% CI −5.16 to −3.66 and adjusted EQ-5D model sex coefficient: −0.07, 95% CI −0.08 to −0.06). Conclusions Women have lower HRQoL compared with men at baseline and during 12 months follow-up after MI. Tailored interventions for women following an MI could improve their quality of life. Trial registration number ClinicalTrials.gov (NCT04598048, NCT01808027, NCT01819103


  • Outcomes of novel pacing technologies with right ventricular pacing as a primary strategy for patient undergoing transvenous permanent pacing regardless of pacing indication

    by A Abdin, S Aktaa, D Vukadinovic, E Arbelo, M Boehm, H Burri, M Glikson, C Meyer, T Munyombwe, N C Nielsen, et al.

    Background: Right ventricular pacing (RVP) may cause electrical and mechanical desynchrony leading to impaired left ventricular ejection fraction (LVEF). We investigated the outcomes of RVP with His bundle pacing (HBP) and left bundle branch pacing (LBBP) for patients requiring a de novo permeant pacemaker (PPM) irrespective of baseline pacing indication. Methods and results: Systematic review of randomized clinical trials and observational studies comparing HBP or LBP with RVP for de novo PPM implantation between 01 January 2013 and 17 November 2020 using MEDLINE and Embase. Two independent reviewers extracted the data and assessed the risk of bias of included studies. Random and fixed effects meta-analyses of the effect of pacing technology on study outcomes (all-cause mortality, heart failure hospitalization (HFH), left ventricular ejection fraction, QRS duration, lead revision, atrial fibrillation and procedure and pacing metrics) were performed. Overall, 7 studies were included. HBP compared with RVP was associated with decreased mortality (risk ratio [RR] 0.76, 95% CI 0.59 to 0.98), preservation of LVEF (mean difference [MD] 1.2, 95% CI −1.37 to 3.8 vs. −5.22, 95% CI: −6.94 to −3.51), increased procedure duration (MD 15.17 min, 95% CI: 11.27 to 19.07) and more lead revisions (RR 6.30, 95% CI: 2.31 to 17.19). LBBP compared with RVP was associated with shorter paced QRS durations (MD 5.6 ms, 95% CI −6.4 to 17.6) vs. (51.0 ms, 95% CI 39.2 to 62.9) and increased procedure durations (MD 37.78 min, 95% CI: 20.04 to 55.51). Conclusion: Of the limited studies published, this meta-analysis found that HBP and LBBP were superior to RVP in maintaining physiological ventricular activation as an initial pacing strategy. Well conducted comparative studies are required to understand the impact of such novel pacing strategies on clinical outcomes. Funding Acknowledgement: Type of funding sources: None.